Price (delayed)
$0.65
Market cap
$98M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.34
Enterprise value
$131.94M
Optinose is a specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy specialists. Optinose has offices in the U.S.
There are no recent dividends present for OPTN.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.